Literature DB >> 23113280

Neurogenesis enhancer RO 25-6981 facilitates repeated spatial learning in adult rats.

O A Soloviova1, A T Proshin, Z I Storozheva, V V Sherstnev.   

Abstract

The effects of Ro 25-6981 (selective NMDA receptor blocker) in a dose stimulating neurogenesis on repeated learning, reversal learning, and memory reconsolidation were studied in adult rats in Morris water maze. Ro 25-6981 facilitated repeated learning 13 days after injection, but did not influence reversal learning. The blocker injected directly before reminder did not disturb repeated learning and reversal learning in Morris water maze. These effects of Ro 25-6981 on the dynamics of repeated learning seemed to be due to its effects on neurogenesis processes in adult brain.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23113280     DOI: 10.1007/s10517-012-1821-6

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  3 in total

1.  Inhibition of NR2B-Containing N-methyl-D-Aspartate Receptors (NMDARs) in Experimental Autoimmune Encephalomyelitis, a Model of Multiple Sclerosis.

Authors:  Mojtaba Farjam; Faegheh Baha'addini Beigi Zarandi; Shirin Farjadian; Bita Geramizadeh; Ali Reza Nikseresht; Mohammad Reza Panjehshahin
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

2.  Ablation of BAF170 in Developing and Postnatal Dentate Gyrus Affects Neural Stem Cell Proliferation, Differentiation, and Learning.

Authors:  Tran Tuoc; Ekrem Dere; Konstantin Radyushkin; Linh Pham; Huong Nguyen; Anton B Tonchev; Guoqiang Sun; Anja Ronnenberg; Yanhong Shi; Jochen F Staiger; Hannelore Ehrenreich; Anastassia Stoykova
Journal:  Mol Neurobiol       Date:  2016-07-08       Impact factor: 5.590

3.  The Neurogenesis Actuator and NR2B/NMDA Receptor Antagonist Ro25-6981 Consistently Improves Spatial Memory Retraining Via Brain Region-Specific Gene Expression.

Authors:  Marina A Gruden; Alexander M Ratmirov; Zinaida I Storozheva; Olga A Solovieva; Vladimir V Sherstnev; Robert D E Sewell
Journal:  J Mol Neurosci       Date:  2018-05-22       Impact factor: 3.444

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.